This is a demo store. No orders will be fulfilled.

Codrituzumab (anti-GPC3), 糖蛋白 3 抗体

    应用:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • 宿主种属: 人(Human)
  • 种属反应性: 人(Human)
  • 亚型: Human IgG1
  • 偶联: Unconjugated
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
Ab170840-100μg
100μg 现货 Stock Image
Ab170840-1mg
1mg 现货 Stock Image
Ab170840-5mg
5mg 现货 Stock Image
Ab170840-10mg
10mg 期货 Stock Image

基本信息

产品名称 Codrituzumab (anti-GPC3), 糖蛋白 3 抗体
别名 考曲妥珠单抗 | Codrituzumab(抗 GPC3)
英文别名 DGSX antibody | Glypican proteoglycan 3 antibody | Glypican-3 [Precursor] antibody | Gpc3 antibody | GPC3_HUMAN antibody | GTR2 2 antibody | GTR2-2 antibody | Heparan sulphate proteoglycan antibody | Intestinal protein OCI 5 antibody | Intestinal protein
规格或纯度 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
宿主种属 人(Human)
特异性 GPC3
种属反应性 人(Human)
偶联 Unconjugated
作用类型 抑制剂
作用机制 糖蛋白 3 抗体

产品属性

克隆类型 重组抗体
Format Whole IgG
亚型 Human IgG1
轻链亚型 kappa
SDS-PAGE 28.4 kDa (Light Chain) & 52.6 kDa (Heavy Chain), under reducing conditions; 178.1 kDa, under non-reducing conditions.
纯化方法 Protein A purified
纯度 >95%
物理外观 Liquid
储存缓冲液 Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂 No
浓度 见COA
储存温度 -80℃储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
CAS编号和信息 1365267-33-9
分子类型 抗体

关联靶点(人)

GPC3 Tbio 磷脂酰肌醇蛋白聚糖-3(Glypican-3) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

图片

Codrituzumab (anti-GPC3) (Ab170840) - ELISA
Immobilized Human GPC3-his at 2 μg/mL can bind Codrituzumab (anti-GPC3) (Ab170840) with the EC₅₀ of 15.34 ng/mL.

Codrituzumab (anti-GPC3) (Ab170840) - SEC
The purity of Codrituzumab (anti-GPC3) (Ab170840) is more than 95% verified by HPLC.

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到7个结果

批号(Lot Number) 证书类型 货号
ZJ25F0723624 分析证书 Ab170840
ZJ24F1113293 分析证书 Ab170840
ZJ24F1113292 分析证书 Ab170840
ZJ24F1113291 分析证书 Ab170840
ZJ24F0202858 分析证书 Ab170840
ZJ24F0202857 分析证书 Ab170840
ZJ24F0202856 分析证书 Ab170840

引用文献

1. Nakano K, Ishiguro T, Konishi H, Tanaka M, Sugimoto M, Sugo I, Igawa T, Tsunoda H, Kinoshita Y, Habu K et al..  (2010)  Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization..  Anticancer Drugs,  21  (10): (907-16).  [PMID:20847643]
2. Davoodi J, Kelly J, Gendron NH, MacKenzie AE.  (2007)  The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26..  Proteomics,  (13): (2300-10).  [PMID:17549790]
3. Pilia, G G and 9 more authors..  (1996)  Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome..  Nature genetics,  [PMID:8589713]
4. Shen, T T and 6 more authors..  (1997)  Mapping of the Simpson-Golabi-Behmel overgrowth syndrome gene (GPC3) to chromosome X in human and rat by fluorescence in situ hybridization..  Mammalian genome : official journal of the International Mammalian Genome Society,  [PMID:9021160]
5. Lage, H H and Dietel, M M..  (1997)  Cloning and characterization of human cDNAs encoding a protein with high homology to rat intestinal development protein OCI-5..  Gene,  (1): [PMID:9133586]
6. Huber, R R and 8 more authors..  (1997)  Analysis of exon/intron structure and 400 kb of genomic sequence surrounding the 5'-promoter and 3'-terminal ends of the human glypican 3 (GPC3) gene..  Genomics,  (1): [PMID:9339360]
7. Veugelers, M M and 11 more authors..  (2000)  Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene..  Human molecular genetics,  (22): [PMID:10814714]
8. Capurro, Mariana M and 6 more authors..  (2003)  Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma..  Gastroenterology,  [PMID:12851874]
9. De Cat, Bart B and 8 more authors..  (2003)  Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements..  The Journal of cell biology,  (10): [PMID:14610063]
10. Hippo, Yoshitaka Y and 19 more authors..  (2004)  Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma..  Cancer research,  (1): [PMID:15059894]
11. Ross, Mark T MT and 281 more authors..  (2005)  The DNA sequence of the human X chromosome..  Nature,  (17): [PMID:15772651]
12. Capurro, Mariana I MI, Xiang, Yun-Yan YY, Lobe, Corrinne C and Filmus, Jorge J..  (2005)  Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling..  Cancer research,  (15): [PMID:16024626]
13. Capurro, Mariana I MI, Shi, Wen W, Sandal, Shaifali S and Filmus, Jorge J..  (2005)  Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth..  The Journal of biological chemistry,  (16): [PMID:16227623]
14. Capurro, Mariana M, Martin, Tonya T, Shi, Wen W and Filmus, Jorge J..  (2014)  Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling..  Journal of cell science,  (1): [PMID:24496449]
15. Capurro, Mariana M, Shi, Wen W, Izumikawa, Tomomi T, Kitagawa, Hiroshi H and Filmus, Jorge J..  (2015)  Processing by convertases is required for glypican-3-induced inhibition of Hedgehog signaling..  The Journal of biological chemistry,  (20): [PMID:25653284]
16. Tagliabracci, Vincent S VS and 14 more authors..  (2015)  A Single Kinase Generates the Majority of the Secreted Phosphoproteome..  Cell,  (18): [PMID:26091039]
17. Saad, Ahmad A and 7 more authors..  (2018)  Role of Glycanation and Convertase Maturation of Soluble Glypican-3 in Inhibiting Proliferation of Hepatocellular Carcinoma Cells..  Biochemistry,  (20): [PMID:29345911]

溶液计算器